Assessment of 18F-Florbetaben Whole-body PET Imaging for the Comprehensive Detection of Cardiac and Extracardiac Sites of Amyloid Deposits
Latest Information Update: 13 Feb 2025
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Amyloid light-chain amyloidosis; Amyloidosis
- Focus Diagnostic use
- Acronyms CAPRI
Most Recent Events
- 11 Feb 2025 Status changed from recruiting to completed.
- 10 Jan 2024 Planned End Date changed from 10 May 2024 to 10 May 2025.
- 10 Jan 2024 Planned primary completion date changed from 30 Dec 2023 to 30 Jan 2025.